Conditions chroniques associées aux infections

Description

COVID longue

maladies_complexes_covid_longue via biblio.chum on Inoreader

Social Determinants of Health and Pediatric Long COVID in the US
on 9 janvier 2026
JAMA Pediatr. 2026 Jan 5. doi: 10.1001/jamapediatrics.2025.5485. Online ahead of print.ABSTRACTIMPORTANCE: Millions of children worldwide are experiencing prolonged symptoms after SARS-CoV-2 […]
Neurological symptoms and physical exam findings 6-11 months post-COVID-19: a cohort study
on 9 janvier 2026
Sci Rep. 2026 Jan 2. doi: 10.1038/s41598-025-33779-w. Online ahead of print.NO ABSTRACTPMID:41484407 | DOI:10.1038/s41598-025-33779-w
Long Covid Syndrome and Role of Autonomic Nervous System
on 9 janvier 2026
Rev Med Virol. 2026 Jan;36(1):e70101. doi: 10.1002/rmv.70101.NO ABSTRACTPMID:41474066 | DOI:10.1002/rmv.70101
Patient perspectives on the usability and content validity of the assessment of burden of chronic conditions tool for post-COVID in the Netherlands: a qualitative study
on 9 janvier 2026
BMJ Open. 2025 Dec 12;15(12):e109201. doi: 10.1136/bmjopen-2025-109201.ABSTRACTBACKGROUND: Post-COVID syndrome manifests with a diverse array of symptoms for which no standard care plan currently […]
Long COVID involves activation of proinflammatory and immune exhaustion pathways
on 9 janvier 2026
Nat Immunol. 2025 Dec 12. doi: 10.1038/s41590-025-02353-x. Online ahead of print.ABSTRACTLong COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome […]
PCE-CfD and Long Covid: An NHS Service Evaluation on the Benefits of Using Person-Centred Experiential Counselling for Depression With People With Long Covid
on 9 janvier 2026
Health Expect. 2025 Dec;28(6):e70517. doi: 10.1111/hex.70517.ABSTRACTBACKGROUND: Long Covid is a condition affecting multiple organ systems and the mental health of patients. To address this, two […]
Long covid pulmonary rehabilitation
on 9 janvier 2026
Rev Mal Respir. 2025 Dec 16:S0761-8425(25)00265-7. doi: 10.1016/j.rmr.2025.12.001. Online ahead of print.ABSTRACTWhile the SARS-CoV-2 pandemic has left a lasting impression, the long-term effects of […]
Could Hidden Infections Be Fueling Long COVID? - Rutgers University
on 9 janvier 2026
Could Hidden Infections Be Fueling Long COVID? Rutgers University
13 Things To Know About Paxlovid, the COVID-19 Pill - Yale Medicine
on 9 janvier 2026
13 Things To Know About Paxlovid, the COVID-19 Pill Yale Medicine
Break in the case for long COVID investigators — Harvard Gazette
on 9 janvier 2026
A new study from investigators at Harvard and Beth Israel Deaconess Medical Center sheds light on why some people never fully recover from COVID-19. In research that analyzed blood samples from more […]
IACI+Provider+Manual+Ver+1.1.pdf
on 9 janvier 2026
Clinical-Care-Guide-First-Edition-2025-1.pdf
on 9 janvier 2026
Long COVID involves activation of proinflammatory and immune exhaustion pathways - Nature
on 9 janvier 2026
Long COVID involves activation of proinflammatory and immune exhaustion pathways Nature
Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19
on 5 Décembre 2025
Nat Commun. 2025 Nov 26;16(1):10552. doi: 10.1038/s41467-025-65597-z.ABSTRACTAlthough brain alterations have been reported in post-acute sequelae of SARS-CoV-2 (PASC), their prevalence and […]
Post-COVID-19 condition patients' utilisation of healthcare resources after implementation of an integrated care unit
on 5 Décembre 2025
Cost Eff Resour Alloc. 2025 Dec 2. doi: 10.1186/s12962-025-00667-z. Online ahead of print.NO ABSTRACTPMID:41331825 | DOI:10.1186/s12962-025-00667-z
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
on 5 Décembre 2025
Lancet Infect Dis. 2025 Nov 7:S1473-3099(25)00665-6. doi: 10.1016/S1473-3099(25)00665-6. Online ahead of print.NO ABSTRACTPMID:41213281 | DOI:10.1016/S1473-3099(25)00665-6
Pursuing Reduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER): a protocol for a randomised feasibility trial
on 5 Décembre 2025
BMJ Open. 2025 Nov 9;15(11):e102112. doi: 10.1136/bmjopen-2025-102112.ABSTRACTINTRODUCTION: Over 777 million COVID-19 infections have occurred globally, with data suggesting that 10%-20% of those […]
Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial
on 5 Décembre 2025
JAMA Netw Open. 2025 Nov 3;8(11):e2534304. doi: 10.1001/jamanetworkopen.2025.34304.ABSTRACTIMPORTANCE: Long COVID presents an unmet therapeutic need.OBJECTIVE: To determine the effects of a […]
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial
on 5 Décembre 2025
JAMA Neurol. 2025 Nov 10. doi: 10.1001/jamaneurol.2025.4415. Online ahead of print.ABSTRACTIMPORTANCE: Treatment for cognitive dysfunction due to postacute sequelae of long COVID (ie, symptoms of […]
A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID - Nature
on 5 Décembre 2025
A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID Nature

COVID longue : lignes directrices canadiennes

Mise à jour du 17 juillet 2025

Mise à jour du 31 mars 2025

Mise à jour du 5 mars 2025

Maladie de Lyme

maladies_complexes_lyme via biblio.chum on Inoreader

Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Sweden
on 9 janvier 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
Early brain changes in Lyme disease are associated with clinical outcomes
on 9 janvier 2026
Brain Behav Immun Health. 2025 Dec 2;50:101153. doi: 10.1016/j.bbih.2025.101153. eCollection 2025 Dec.ABSTRACTIn Lyme disease (LD), 10-20 % of patients develop persistent symptoms following […]
A human Lyme disease vaccine: two steps forward on the path to prevention
on 9 janvier 2026
Expert Rev Vaccines. 2025 Dec 21:2607482. doi: 10.1080/14760584.2025.2607482. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
Guidelines for Lyme borreliosis: treatment
on 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105204. doi: 10.1016/j.idnow.2025.105204. Epub 2025 Nov 26.ABSTRACTThe aim of the clinical practice guideline is to support healthcare professionals in the diagnosis […]
Guidelines for Lyme borreliosis: clinical manifestations
on 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105202. doi: 10.1016/j.idnow.2025.105202. Epub 2025 Nov 28.ABSTRACTLyme borreliosis (LB) is a tick-borne zoonosis caused by spirochetes belonging to the Borrelia […]
Guidelines for Lyme borreliosis: Diagnostic strategies
on 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105203. doi: 10.1016/j.idnow.2025.105203. Epub 2025 Nov 26.ABSTRACTThe diagnosis of Lyme borreliosis (LB) relies primarily on clinical evaluation supported by […]
Quantifying the Public Health Impact of Lyme Disease in Minnesota: A Simulation Analysis of Reported and Unreported Cases
on 5 Décembre 2025
J Health Econ Outcomes Res. 2025 Nov 20;12(2):221-228. doi: 10.36469/001c.146618. eCollection 2025.ABSTRACTBackground: Lyme disease, the most common vector-borne disease in Minnesota, is estimated to […]
Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease
on 5 Décembre 2025
NPJ Vaccines. 2025 Dec 4. doi: 10.1038/s41541-025-01326-3. Online ahead of print.ABSTRACTThere is currently no Lyme disease (LD) vaccine available for use in humans. Outer surface protein C (OspC) of […]
Genetic landscape of Borrelia burgdorferi sensu stricto in Canada: a study of genetic diversity
on 5 Décembre 2025
Sci Rep. 2025 Nov 20;15(1):40954. doi: 10.1038/s41598-025-24758-2.ABSTRACTBorrelia burgdorferi sensu stricto (s.s.), the causative agent of Lyme disease in North America, exhibits considerable […]
Guidelines for Lyme borreliosis: post-treatment Lyme disease syndrome (PTLDS)
on 5 Décembre 2025
Infect Dis Now. 2025 Nov 26:105205. doi: 10.1016/j.idnow.2025.105205. Online ahead of print.ABSTRACTPersistent symptoms following appropriate treatment of confirmed Lyme borreliosis (LB) require a […]
Risk Factors for Lyme Disease in the General Population-A Survey of Adults and Caregivers in 28 States
on 5 Décembre 2025
Open Forum Infect Dis. 2025 Oct 21;12(11):ofaf658. doi: 10.1093/ofid/ofaf658. eCollection 2025 Nov.ABSTRACTBACKGROUND: There are an estimated 476 000 diagnosed and treated cases of Lyme disease (LD) […]
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis
on 7 novembre 2025
Ger Med Sci. 2025 Oct 9;23:Doc13. doi: 10.3205/000349. eCollection 2025.ABSTRACTLyme disease is the most common tick-borne infectious disease in Europe. Neurological manifestations occur in 3-15% of […]
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society
on 7 novembre 2025
Ger Med Sci. 2025 Oct 9;23:Doc12. doi: 10.3205/000348. eCollection 2025.ABSTRACTThe current S2k guideline "kutane Borreliose" has been updated in accordance with the methodological standards of the […]
Identification of potential biomarkers for Lyme disease using bioinformatics and machine learning
on 7 novembre 2025
Clin Exp Med. 2025 Oct 31;25(1):341. doi: 10.1007/s10238-025-01803-y.ABSTRACTLyme disease (LD) presents significant diagnostic challenges due to the absence of a reliable screening method for initial […]
The diagnostic potential of proteomics and machine learning in Lyme neuroborreliosis
on 7 novembre 2025
Nat Commun. 2025 Oct 27;16(1):9322. doi: 10.1038/s41467-025-64903-z.ABSTRACTLyme neuroborreliosis (LNB), a nervous system infection caused by tick-borne spirochetes of the Borrelia burgdorferi sensu […]
Late Lyme neuroborreliosis encephalomyelitis with distinct MRI features-a case report and systematic literature review
on 7 novembre 2025
J Neurol. 2025 Oct 26;272(11):729. doi: 10.1007/s00415-025-13475-5.ABSTRACTBACKGROUND: Central nervous system (CNS) Lyme neuroborreliosis (LNB) rarely occurs. Clinical and radiological findings are […]
Targeted volume imaging reveals early vascular interactions of Lyme disease pathogen in skin
on 7 novembre 2025
Nat Commun. 2025 Oct 22;16(1):9330. doi: 10.1038/s41467-025-64326-w.ABSTRACTAlthough the contours of the dissemination pathways of human pathogenic spirochetes in the vertebrate hosts are known, […]
Atypical facial oedema in acrodermatitis chronica atrophicans: A potential clue for early diagnosis in Lyme disease
on 7 novembre 2025
Clin Exp Dermatol. 2025 Oct 11:llaf450. doi: 10.1093/ced/llaf450. Online ahead of print.NO ABSTRACTPMID:41074274 | DOI:10.1093/ced/llaf450
The multiplexed single-tier InBios Lyme Detect Multiplex ELISA is more sensitive than standard two-tier tests in the early stages of Lyme disease
on 7 novembre 2025
J Clin Microbiol. 2025 Oct 9:e0062925. doi: 10.1128/jcm.00629-25. Online ahead of print.ABSTRACTThere are nearly 500,000 cases of Lyme disease each year in the United States; 10%-20% of them result […]
Transendothelial migration of the Lyme disease spirochete involves spirochete internalization as an intermediate step through a transcellular pathway that involves Cdc42 and Rac1 - PubMed
on 6 octobre 2025
Despite its importance in pathogenesis, the hematogenous dissemination pathway of B. burgdorferi is still largely uncharacterized. To probe the molecular details of transendothelial migration more […]

Encéphalomyélite myalgique

maladies_complexes_encephalomyelite via biblio.chum on Inoreader

Tuina therapy for patients with chronic fatigue syndrome: a randomized controlled trial
on 9 janvier 2026
J Transl Med. 2026 Jan 8. doi: 10.1186/s12967-025-07624-7. Online ahead of print.ABSTRACTBACKGROUND: Chronic fatigue syndrome (CFS) is a complex and disabling disorder characterized by persistent […]
Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control study
on 9 janvier 2026
J Transl Med. 2026 Jan 8. doi: 10.1186/s12967-025-07620-x. Online ahead of print.ABSTRACTBACKGROUND: In recent years, evidence has indicated a metabolic shift towards increased demand for lipids in […]
Evaluating working memory functioning in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis
on 9 janvier 2026
Psychol Health Med. 2026 Jan 8:1-30. doi: 10.1080/13548506.2025.2606183. Online ahead of print.ABSTRACTIndividuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) frequently report […]
Wheat and chaff in Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) in clinics and laboratory
on 9 janvier 2026
J Transl Med. 2026 Jan 5;24(1):20. doi: 10.1186/s12967-025-07397-z.NO ABSTRACTPMID:41491817 | DOI:10.1186/s12967-025-07397-z
Theoretical foundation of the Activity Calculator - a method for fatigue management
on 9 janvier 2026
Scand J Occup Ther. 2025 Jan;32(1):2608471. doi: 10.1080/11038128.2025.2608471. Epub 2025 Dec 31.ABSTRACTBACKGROUND: Chronic fatigue impacts individuals' ability to engage in daily activities and […]
Age-specific alterations of the gut mycobiome in patients with myalgic encephalomyelitis/chronic fatigue syndrome and identification of potential diagnostic biomarkers
on 9 janvier 2026
BMC Microbiol. 2025 Dec 30. doi: 10.1186/s12866-025-04650-9. Online ahead of print.NO ABSTRACTPMID:41469536 | DOI:10.1186/s12866-025-04650-9
Comparative efficacy of various exercise therapies for chronic fatigue syndrome: A systematic review and network meta-analysis
on 9 janvier 2026
iScience. 2025 Nov 21;28(12):114178. doi: 10.1016/j.isci.2025.114178. eCollection 2025 Dec 19.ABSTRACTTo systematically compare the effectiveness of different exercise therapies for chronic fatigue […]
Sustained illness burden over time among Australians with myalgic encephalomyelitis/chronic fatigue syndrome
on 9 janvier 2026
PLoS One. 2025 Dec 29;20(12):e0338433. doi: 10.1371/journal.pone.0338433. eCollection 2025.ABSTRACTBACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling chronic […]
Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies Are a Recurrent Hallmark in Post-Infectious ME/CFS and is Associated With Fatigue
on 9 janvier 2026
J Med Virol. 2026 Jan;98(1):e70769. doi: 10.1002/jmv.70769.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease with unknown etiology and heterogeneous […]
Histone phosphorylation analysis of two main TCM syndromes of chronic fatigue syndrome
on 9 janvier 2026
J Transl Med. 2025 Dec 25. doi: 10.1186/s12967-025-07579-9. Online ahead of print.ABSTRACTOBJECTIVE: This study aimed to investigate differences in protein expression, protein function, and […]
Diagnosis of chronic fatigue syndrome using beat-to-beat autonomic measurements
on 9 janvier 2026
J Transl Med. 2025 Dec 23;23(1):1413. doi: 10.1186/s12967-025-07433-y.ABSTRACTBACKGROUND: An artificial intelligence (AI) pipeline was used to differentiate patients suffering from Chronic Fatigue […]
Mapping the complexity of ME/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction
on 9 janvier 2026
Cell Rep Med. 2025 Dec 16;6(12):102514. doi: 10.1016/j.xcrm.2025.102514.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder with undefined mechanisms, no […]
How pandemics reshape our brain: Common links and targets between long-haul COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), oxidative stress, and neurodegeneration
on 9 janvier 2026
Neuroprotection. 2025 May 29;3(3):280-287. doi: 10.1002/nep3.70007. eCollection 2025 Sep.ABSTRACTFatiguing syndromes affect millions of patients in the United States and globally, but are grossly […]
Heightened prevalence of chronic fatigue syndrome in U.S. sexual minorities
on 9 janvier 2026
J Psychiatr Res. 2025 Dec 11;193:468-471. doi: 10.1016/j.jpsychires.2025.12.024. Online ahead of print.ABSTRACTPURPOSE: To assess the prevalence and odds of chronic fatigue syndrome (CFS) among […]
Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome
on 9 janvier 2026
Sci Rep. 2025 Dec 12;15(1):43681. doi: 10.1038/s41598-025-27564-y.ABSTRACTTo investigate differences in gut microbiota composition and short-chain fatty acids (SCFAs) metabolism between patients with […]
Abnormal T-Cell activation and cytotoxic T-Cell frequency discriminate symptom severity in myalgic encephalomyelitis/chronic fatigue syndrome
on 9 janvier 2026
J Transl Med. 2025 Dec 10. doi: 10.1186/s12967-025-07507-x. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but […]
Virus Genome Sequences in the Blood of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
on 5 Décembre 2025
medRxiv [Preprint]. 2025 Nov 7:2025.11.06.25339689. doi: 10.1101/2025.11.06.25339689.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a baffling disease. The disease has a wide […]
Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS
on 5 Décembre 2025
Cell Rep Med. 2025 Nov 18;6(11):102449. doi: 10.1016/j.xcrm.2025.102449. Epub 2025 Nov 7.ABSTRACTLong COVID (LC) manifests with sex-specific differences, particularly in those with myalgic […]
Contested and neglected: Social and medical marginalization in severe Chronic Fatigue Syndrome
on 5 Décembre 2025
Soc Sci Med. 2025 Nov 8;388:118766. doi: 10.1016/j.socscimed.2025.118766. Online ahead of print.ABSTRACTThis study addresses the persistent invisibility of people with severe Myalgic […]
Experiences and challenges of staying employed with chronic fatigue syndrome
on 7 novembre 2025
Author Names: Surendran G.,Jose T.P. Database Source: Embase Daily Updates Journal Title: Discover public health Article […]

Syndrome d'Ehlers-Danlos

maladies_complexes_syndrome_ehlers_danlos 2 via biblio.chum on Inoreader

Outcomes and experiences of patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders undergoing surgical interventions: a scoping review
on 9 janvier 2026
Rheumatol Int. 2026 Jan 6;46(1):29. doi: 10.1007/s00296-025-06062-4.NO ABSTRACTPMID:41493475 | DOI:10.1007/s00296-025-06062-4
Nutrient intake, dietary patterns and relationship to symptoms and comorbidities in hypermobile Ehlers-Danlos syndrome
on 9 janvier 2026
Clin Nutr. 2025 Dec 9;56:106538. doi: 10.1016/j.clnu.2025.11.022. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Hypermobile Ehlers Danlos Syndrome (hEDS) patients have a high prevalence of […]
A de novo variant of the COL3A1 gene: causality of vascular Ehlers-Danlos syndrome
on 9 janvier 2026
Adv Lab Med. 2025 Nov 26;6(4):500-503. doi: 10.1515/almed-2025-0172. eCollection 2025 Dec.ABSTRACTOBJECTIVES: To establish diagnosis of vascular Ehlers-Danlos syndrome (VEDS) through genetic testing. […]
Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals
on 9 janvier 2026
Aliment Pharmacol Ther. 2025 Dec 23. doi: 10.1111/apt.70506. Online ahead of print.ABSTRACTBACKGROUND: Ehlers-Danlos syndrome (EDS) comprises inherited connective tissue disorders characterised by […]
The association of point-of-care coagulation testing with bleeding symptoms in patients with Ehlers-Danlos syndrome: an exploratory cross-sectional study
on 9 janvier 2026
Can J Anaesth. 2025 Dec 19. doi: 10.1007/s12630-025-03048-5. Online ahead of print.ABSTRACTPURPOSE: Ehlers-Danlos syndromes (EDS) are a group of connective tissue disorders associated with an […]
Sources and consequences of self-doubt in patients with Ehlers-Danlos syndrome: a qualitative study in Europe and North America
on 9 janvier 2026
BMJ Open. 2025 Dec 12;15(12):e109681. doi: 10.1136/bmjopen-2025-109681.ABSTRACTOBJECTIVES: To examine how clinicians' scepticism regarding patients' self-reports of subjective symptoms can be […]
Comparative assessment of left common iliac vein compression in patients with hypermobile Ehlers-Danlos syndrome, hypermobility spectrum disorder and healthy controls - A retrospective single-centre study
on 5 Décembre 2025
Phlebology. 2025 Nov 17:2683555251400392. doi: 10.1177/02683555251400392. Online ahead of print.ABSTRACTObjectivesHeritable connective tissue disorders (HCTDs), including hypermobile Ehlers-Danlos […]
Associations Between Pain and Substance Use Among Individuals Diagnosed with Ehlers-Danlos Syndromes or Generalized Hypermobility Spectrum Disorder
on 5 Décembre 2025
Int J Behav Med. 2025 Nov 11. doi: 10.1007/s12529-025-10409-3. Online ahead of print.ABSTRACTBACKGROUND: Pain and substance use frequently co-occur. Research indicates pain motivates alcohol, […]
Connective tissue changes in Ehlers-Danlos syndromes with and without axial spondyloarthropathy
on 7 novembre 2025
J Ultrasound. 2025 Nov 4. doi: 10.1007/s40477-025-01092-x. Online ahead of print.ABSTRACTPURPOSE: Ehlers-Danlos Syndromes (EDS) are a group of connective tissue disorders characterized by joint […]
Co-morbid monogenic disorders at chromosome region 1q2: LMNA- and FLG-related disorders in a patient referred for assessment of joint hypermobility
on 7 novembre 2025
Chromosome Res. 2025 Oct 30;33(1):24. doi: 10.1007/s10577-025-09785-z.ABSTRACTThe phenotypic similarities and genetic heterogeneity occurring in diverse forms of Ehlers Danlos Syndrome (EDS) subtypes […]
Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndrome
on 7 novembre 2025
Auton Neurosci. 2025 Oct 14;262:103356. doi: 10.1016/j.autneu.2025.103356. Online ahead of print.ABSTRACTBACKGROUND: Hypermobility Spectrum Disorders (HSD) and hypermobile Ehlers-Danlos syndrome […]
Percutaneous transhepatic coil embolisation of a common hepatic artery aneurysm in vascular Ehlers-Danlos syndrome
on 7 novembre 2025
CVIR Endovasc. 2025 Oct 16;8(1):85. doi: 10.1186/s42155-025-00600-8.ABSTRACTBACKGROUND: Vascular Ehlers-Danlos syndrome is a rare connective tissue disorder characterised by arterial fragility, […]
Evidence of Altered Enteric Nervous System Structure Associated With Severe Dysmotility in a Patient With Ehlers-Danlos Syndrome
on 6 octobre 2025
ACG Case Rep J. 2025 Sep 24;12(9):e01823. doi: 10.14309/crj.0000000000001823. eCollection 2025 Sep.ABSTRACTPatients with Ehlers-Danlos syndrome (EDS) suffer from gastroparesis, constipation, and gut […]
Outcomes of revisional bariatric surgery in patient with hypermobile Ehlers-Danlos syndrome
on 6 octobre 2025
J Surg Case Rep. 2025 Sep 30;2025(9):rjaf782. doi: 10.1093/jscr/rjaf782. eCollection 2025 Sep.ABSTRACTEhlers-Danlos syndrome (EDS), a rare group of inherited connective tissue disorders caused by […]
Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study
on 6 octobre 2025
LGBT Health. 2025 Sep 23. doi: 10.1177/23258292251382250. Online ahead of print.ABSTRACTPurpose: This study compared the prevalence of hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility […]
Varied Presentations of Arterial Events in Vascular Ehlers-Danlos Syndrome
on 6 octobre 2025
JACC Case Rep. 2025 Sep 12:105424. doi: 10.1016/j.jaccas.2025.105424. Online ahead of print.ABSTRACTSpontaneous arterial aneurysms and dissections are relatively common in patients with vascular […]
Ehlers-Danlos syndromes: Diagnosis and care pathway of these complex and multisystemic diseases
on 1 septembre 2025
Rev Med Interne. 2025 Aug 30:S0248-8663(25)00722-2. doi: 10.1016/j.revmed.2025.08.002. Online ahead of print.ABSTRACTEhlers-Danlos syndromes (EDS) are a heterogeneous group of rare and inherited […]
A unique case of prenatal diagnosis of vascular Ehlers-Danlos syndrome
on 1 septembre 2025
Int J Gynaecol Obstet. 2025 Aug 7. doi: 10.1002/ijgo.70431. Online ahead of print.ABSTRACTWe present a rare instance of prenatal diagnosis of vEDS without a family history. The suspicion of a genetic […]
B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome
on 1 septembre 2025
JCI Insight. 2025 Aug 22;10(16):e179474. doi: 10.1172/jci.insight.179474. eCollection 2025 Aug 22.ABSTRACTEhlers-Danlos syndromes (EDS) comprise a genetically and clinically heterogenous group of […]
Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features
on 1 septembre 2025
Am J Med Open. 2025 Jul 18;14:100111. doi: 10.1016/j.ajmo.2025.100111. eCollection 2025 Dec.ABSTRACTBACKGROUND: Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive […]

Études cliniques

maladies_complexes_etudes_cliniques via biblio.chum on Inoreader

The Effect of the Human Regenerator Jet Device on the Quality of Life of Adult Individuals [HR-QoL]
on 9 janvier 2026
Conditions: Chronic Stress; Chronic Fatigue; Chronic Pain; Post-COVID / Long-COVID Interventions: Device: Cold Atmospheric Plasma; Device: Atmospheric Air Sponsors: University of Athens; THE […]
Immunoadsorption in Autoimmune Long COVID
on 9 janvier 2026
Conditions: Long COVID; Long COVID Syndrome; Long COVID-19 Syndrome; Post COVID Syndrome Interventions: Device: Immunoadsorption; Device: Sham Comparator Sponsors: Academisch Medisch Centrum - […]
Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
on 9 janvier 2026
Conditions: PASC Post Acute Sequelae of COVID 19; Fatigue Interventions: Behavioral: Physical Fatigue Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; National Institute of […]
RECLAIM Adaptive Platform Trial for PCC Treatments
on 9 janvier 2026
Conditions: Post COVID Condition Interventions: Drug: Metformin; Drug: colchicine Sponsors: Janneke van de Wijgert; European Clinical Research Alliance for Infectious Diseases (ECRAID) Enrolling […]
Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
on 9 janvier 2026
Conditions: Persistent COVID Condition Interventions: Other: BioICOPER Long COVID Cohort Sponsors: Instituto de Investigación Biomédica de Salamanca; Carlos III Health Institute Not yet […]
Acupuncture and Chinese Herbal Medicine for Long COVID
on 9 janvier 2026
Conditions: Long COVID Interventions: Procedure: Acupuncture Sponsors: Southern California University of Health Sciences Recruiting
Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial
on 9 janvier 2026
Conditions: Post COVID Condition Interventions: Drug: Sonlicromanol; Drug: Placebo Sponsors: Michele van Vugt; ZonMw: The Netherlands Organisation for Health Research and Development; Khondrion BV […]
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
on 9 janvier 2026
Conditions: Long COVID Syndrome Interventions: Dietary Supplement: Taurine supplementation Sponsors: York University; Long COVID Web; Canadian Institutes of Health Research (CIHR) Not yet […]
Whole-Body Electrostimulation for Functional Recovery in Post-COVID Syndrome
on 9 janvier 2026
Conditions: Post COVID Syndrome Long Covid; Post COVID Syndrome; Long COVID Fatigue; Long Covid Interventions: Device: Whole-Body Electromyostimulation Suit Sponsors: Universidad Rey Juan Carlos […]
Design and Validation of Innovative Strategies Based on Dual-Task Approach
on 9 janvier 2026
Conditions: Stroke; Multiple Sclerosis; Parkinson Disease; Dual Task Exercises; Long COVID Interventions: Other: Dual Task exercise; Other: Physical therapy Sponsors: I.R.C.C.S. Fondazione Santa […]
Brain Stimulation in Long COVID
on 9 janvier 2026
Conditions: Long COVID; PASC Post Acute Sequelae of COVID 19; Post COVID-19 Condition (PCC) Interventions: Device: Repetitive Transcranial Magnetic Stimulation; Device: Sham device Sponsors: […]
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
on 9 janvier 2026
Conditions: Myocarditis; Heart Failure; Myocardial Fibrosis; Vascular Inflammation; Long COVID Syndrome Interventions: Diagnostic Test: Cardiac Imaging Sponsors: Johann Wolfgang Goethe University […]
PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway
on 5 Décembre 2025
Conditions: Post COVID-19 Condition, Unspecified; SARS-CoV2 Infection; COVID-19 Interventions: Drug: Nirmatrelvir/ritonavir; Drug: Placebo Sponsors: Haukeland University Hospital; University of […]
Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom
on 5 Décembre 2025
Conditions: Post-COVID-19 Syndrome Interventions: Behavioral: Exercise Therapy; Behavioral: Psychotherapy Sponsors: Hannover Medical School; Health Insurance Audi BKK; occupational health service […]
Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity
on 5 Décembre 2025
Conditions: Post-acute Sequelae of SARS-CoV-2 Infection Interventions: Behavioral: Exercise Sponsors: University of Colorado, Denver Recruiting
Harnessing Optimism and Perseverance in the Face of Long COVID-Español
on 7 novembre 2025
Conditions: Post-Acute COVID-19 Syndrome Interventions: Behavioral: HOPE-LC~Espanol Sponsors: Icahn School of Medicine at Mount Sinai Not yet recruiting
LIFT: Life Improvement Trial
on 7 novembre 2025
Conditions: ME/CFS; Long COVID; PASC Interventions: Drug: Pyridostigmine; Drug: Low-Dose Naltrexone; Other: Placebo Sponsors: Brigham and Women's Hospital; Open Medicine Foundation Recruiting
Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome
on 3 octobre 2025
Conditions: Post-COVID-19 Syndrome Interventions: Behavioral: Complementary self-help strategies in addition to treatment as usual; Other: Treatment as usual Sponsors: Universität Duisburg-Essen […]
Immunoadsorption vs. Sham Treatment in Post COVID-19 Patients With Chronic Fatigue Syndrome
on 3 octobre 2025
Conditions: Fatigue; Post-Acute COVID-19 Syndrome Interventions: Procedure: Immunoadsorption vs. sham immunoadsorption Sponsors: Hannover Medical School Completed
Chronic Stress as a Risk Factor for Long COVID
on 3 octobre 2025
Conditions: Long COVID; Acute COVID-19 Sponsors: Medical University of Graz; University of Klagenfurt; Wayne State University Completed

Revue d'actualités

maladies_complexes_actualites via biblio.chum on Inoreader

A Letter from John Aucott, MD : Johns Hopkins Lyme Disease Research Center
on 9 janvier 2026
The December 15, 2025 Health and Human Services (HHS) “Invisible Illness” Lyme Disease Roundtable marked a pivotal federal acknowledgment that Lyme disease is a serious, chronic, biologically […]
Biting back at Lyme disease
on 9 janvier 2026
Nat Med. 2026 Jan 6. doi: 10.1038/d41591-026-00001-x. Online ahead of print.NO ABSTRACTPMID:41495451 | DOI:10.1038/d41591-026-00001-x
Researchers identify viral suspects that could be fueling long COVID - ScienceDaily
on 9 janvier 2026
Researchers identify viral suspects that could be fueling long COVID ScienceDaily
Resistance Training Improves Long COVID Outcomes
on 5 Décembre 2025
JAMA. 2025 Nov 21. doi: 10.1001/jama.2025.19746. Online ahead of print.NO ABSTRACTPMID:41269680 | DOI:10.1001/jama.2025.19746
U of A research explores reasons for higher long-COVID rate among women - CTV News
on 5 Décembre 2025
U of A research explores reasons for higher long-COVID rate among women CTV News
8 trajectories for long COVID - Harvard Gazette
on 3 Décembre 2025
8 trajectories for long COVID Harvard Gazette
Why women may experience long COVID at a higher rate than men - CTV News
on 3 Décembre 2025
Why women may experience long COVID at a higher rate than men CTV News
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease - The Lancet
on 3 Décembre 2025
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease The Lancet
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme - lesoleil.com
on 3 Décembre 2025
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme lesoleil.com
Why is ‘chronic’ lyme disease so controversial? – podcast
on 7 novembre 2025
Long COVID is here to stay—even in children - The Lancet
on 7 novembre 2025
Long COVID is here to stay—even in children The Lancet
New research sheds light on why brain fog is a common symptom of long COVID. - Psychology Today
on 7 novembre 2025
New research sheds light on why brain fog is a common symptom of long COVID. Psychology Today
Scientists may have discovered what’s behind long COVID-related brain fog - Toronto Star
on 7 novembre 2025
Scientists may have discovered what’s behind long COVID-related brain fog Toronto Star
Vivre avec la COVID longue : une exposition donne la parole aux malades - Radio-Canada
on 7 novembre 2025
Vivre avec la COVID longue : une exposition donne la parole aux malades Radio-Canada
Enfin de l’espoir pour le syndrome de fatigue chronique - Le Devoir
on 7 novembre 2025
Enfin de l’espoir pour le syndrome de fatigue chronique Le Devoir
Lyme disease: 'My independence is gone completely' after tick bite - BBC
on 6 octobre 2025
Lyme disease: 'My independence is gone completely' after tick bite BBC
RFK Jr. nomme un chercheur controversé à la tête d’un comité sur la COVID longue - Radio-Canada
on 3 octobre 2025
RFK Jr. nomme un chercheur controversé à la tête d’un comité sur la COVID longue Radio-Canada
Estrie | Une nouvelle fièvre transmise par une tique est recensée - La Presse
on 1 septembre 2025
Estrie | Une nouvelle fièvre transmise par une tique est recensée La Presse
Les dérives de la maladie de Lyme | Bonsoir bonsoir! - Radio-Canada
on 1 septembre 2025
Les dérives de la maladie de Lyme | Bonsoir bonsoir! Radio-Canada
COVID longue et retour à la vie professionnelle : pas tout le monde est chanceux - Radio-Canada
on 10 juillet 2025
COVID longue et retour à la vie professionnelle : pas tout le monde est chanceux Radio-Canada

Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.

Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.

Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.

Avis de non-responsabilité

1. EXCLUSION DE GARANTIES ET LIMITATION DE RESPONSABILITÉ

Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit.

Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.

2. RESPONSABILITÉ RELATIVES AUX LIENS

Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées.

Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.

3. PROPRIÉTÉ INTELLECTUELLE

Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42).

Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité.

Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables.